Name | Recombinant Human Siglec-9 Fc Chimera Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 1139-SL |
Category | Protein |
Prices | $171.08, $329.00 |
Sizes | 50 µg, 50 µg |
Species Reactivities | Human |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Human Siglec-9 (Gln18 - Gly348) Accession # Q9Y336 DIEGRMD Human IgG 1 (Pro100 - Lys330) N-terminus C-terminus |
Purity | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. Kelm, S. et al . (1994) Current Biology 4 :965. The ED 50 for this effect is 1‑5 µg/mL. |
Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | Q9Y336 |
Gene | SIGLEC9 |
Sequence | No results obtained: Gln18 predicted |
Supplier Page | Shop |
Ito T, Ishigami M, Matsushita Y, Hirata M, Matsubara K, Ishikawa T, Hibi H, Ueda M, Hirooka Y, Goto H, Yamamoto A. Sci Rep. 2017 Mar 8;7:44043.
Matsumoto T, Takahashi N, Kojima T, Yoshioka Y, Ishikawa J, Furukawa K, Ono K, Sawada M, Ishiguro N, Yamamoto A. Arthritis Res Ther. 2016 Jun 7;18(1):133.
Matsubara K, Matsushita Y, Sakai K, Kano F, Kondo M, Noda M, Hashimoto N, Imagama S, Ishiguro N, Suzumura A, Ueda M, Furukawa K, Yamamoto A. J Neurosci. 2015 Feb 11;35(6):2452-64.
Chen GY, Brown NK, Wu W, Khedri Z, Yu H, Chen X, van de Vlekkert D, D'Azzo A, Zheng P, Liu Y. Elife. 2014 Sep 3;3:e04066.
Zou Z, Chastain A, Moir S, Ford J, Trandem K, Martinelli E, Cicala C, Crocker P, Arthos J, Sun PD. PLoS One. 2011;6(9):e24559.